“Medifacts International, Inc., one of the largest global providers of noninvasive cardiovascular diagnostic services, today announced that they are once again leading the Cardiovascular Safety Services marketplace in innovation, expertise, and execution – this time with new innovations in the use of telemedicine, T-SMBP (Telemonitoring Self Measured Blood Pressure), in clinical trials.
T-SMBP allows for remote collection of blood pressure (BP) data from a subject’s home. Telemonitoring and telemedicine are actively being implemented through health care providers for general patient care, specifically in patients being treated for heart failure, diabetes, cancer and hypertension.”
Article
The Medical News, 17 December 2009
